🇨🇦Dana Hosseini

Dana Hosseini has over 25 years of experience in the healthcare and biotechnology industries. 🇨🇦Dana began their career in 1991 as Manager of Purchasing at Vancouver Hospital & Health Sciences Centre. In 1995, they became Manager of Contract Marketing at Abbott Laboratories. In 1998, they joined Sequenom as VP of Business Development and supported the company's successful IPO. In 2002, they were VP of Business Development at Cyntellect and Principal at Sci Tech Consulting Services Inc. In 2003, they became CEO of Iceland Genomics Corporation and in 2006, VP of Oncology at DeCODE Genetics. In 2007, they co-founded DiThera Inc. and served as President. In 2013, they co-founded ProdermIQ, Inc. and served as CEO. Finally, in 2016, they co-founded Seqster and currently serves as Chief Business Officer.

Dana Hosseini attended The University of British Columbia from 1984 to 1992, where they obtained a B.Sc. MBA in Biochemistry and Molecular Biology.